Literature DB >> 15559678

Acute toxic effects of club drugs.

Robert S Gable1.   

Abstract

This article summarizes the short-term physiological toxicity and the adverse behavioral effects of four substances (GHB, ketamine, MDMA, and Rohypnol) that have been used at latenight dance clubs. The two primary data sources were case studies of human fatalities and experimental studies with laboratory animals. A safety ratio was calculated for each substance based on its estimated lethal dose and its customary recreational dose. GHB (gamma-hydroxybutyrate) appears to be the most physiologically toxic; Rohypnol (flunitrazepam) appears to be the least physiologically toxic. The single most risk-producing behavior of club drug users is combining psychoactive substances, usually involving alcohol. Hazardous drug-use sequelae such as accidents, aggressive behavior, and addiction were not factored into the safety ratio estimates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15559678     DOI: 10.1080/02791072.2004.10400031

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  10 in total

1.  Differences in club drug use between heterosexual and lesbian/bisexual females.

Authors:  Jeffrey T Parsons; Brian C Kelly; Brooke E Wells
Journal:  Addict Behav       Date:  2006-04-24       Impact factor: 3.913

2.  Illicit drug use among rave attendees in a nationally representative sample of US high school seniors.

Authors:  Joseph J Palamar; Marybec Griffin-Tomas; Danielle C Ompad
Journal:  Drug Alcohol Depend       Date:  2015-05-13       Impact factor: 4.492

Review 3.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

4.  Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches.

Authors:  Raquel Bennett; Christian Yavorsky; Gary Bravo
Journal:  Front Psychiatry       Date:  2022-05-23       Impact factor: 5.435

5.  High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users.

Authors:  Susan Y Kim; Ilene B Anderson; Jo Ellen Dyer; Judith C Barker; Paul D Blanc
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

Review 6.  Ketamine : from medicine to misuse.

Authors:  Kim Wolff; Adam R Winstock
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 7.  Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Authors:  Zurina Hassan; Oliver G Bosch; Darshan Singh; Suresh Narayanan; B Vicknasingam Kasinather; Erich Seifritz; Johannes Kornhuber; Boris B Quednow; Christian P Müller
Journal:  Front Psychiatry       Date:  2017-08-18       Impact factor: 4.157

Review 8.  Ketamine-New Possibilities in the Treatment of Depression: A Narrative Review.

Authors:  Mateusz Kowalczyk; Edward Kowalczyk; Paweł Kwiatkowski; Łukasz Łopusiewicz; Monika Sienkiewicz; Monika Talarowska
Journal:  Life (Basel)       Date:  2021-11-05

9.  Modification of ethanol's reinforcing effectiveness in rhesus monkeys by cocaine, flunitrazepam, or gamma-hydroxybutyrate.

Authors:  Gail Winger; Chad M Galuska; Steven R Hursh
Journal:  Psychopharmacology (Berl)       Date:  2007-05-18       Impact factor: 4.415

10.  Behavioral effects of ketamine and toxic interactions with psychostimulants.

Authors:  Tamaki Hayase; Yoshiko Yamamoto; Keiichi Yamamoto
Journal:  BMC Neurosci       Date:  2006-03-16       Impact factor: 3.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.